Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Evaluation of Optina Retina Scans to Detect the Likeley Cerebral Amyloid Status (CAS) as Determined by Prospective PET Imaging
Authors not listed
Optina Diagnostics Inc. · 2022
Abstract
This is a non-randomized, non-treatment, observational study designed to discover correlations between retinal imaging and amyloid PET imaging. Subjects will be recruited to the clinical cohort from referring physicians. Subjects may be participants from existing studies and clinical practices
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-26 MST
Cite this
APA
Anonymous. (2022). Evaluation of Optina Retina Scans to Detect the Likeley Cerebral Amyloid Status (CAS) as Determined by Prospective PET Imaging. <em>Optina Diagnostics Inc.</em>. https://clinicaltrials.gov/study/NCT05215782
Vancouver
Anonymous. Evaluation of Optina Retina Scans to Detect the Likeley Cerebral Amyloid Status (CAS) as Determined by Prospective PET Imaging. Optina Diagnostics Inc.. 2022.
BibTeX
@misc{anon2022Evalua,
title = {Evaluation of Optina Retina Scans to Detect the Likeley Cerebral Amyloid Status (CAS) as Determined by Prospective PET Imaging},
author = {Anonymous},
journal = {Optina Diagnostics Inc.},
year = {2022},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Mayo Clinic 2008
Open access · US-GOV
Brain Amyloid Imaging With Pittsburgh Compound B in Normal Aging, Mild Cognitive Impairment, and Dementia
University of Zurich 2015
Open access · US-GOV
Investigating the Clinical Consequences of Flutemetamol-PET-scanning
Ophthalmology 2017
Open access · CC-BY
The Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration
Sinotau Pharmaceutical Group 2021
Open access · US-GOV
Single-arm, Single-center, Non-randomized, Open-label Study on the Application of Amyloid Imaging Agent [18F]Florbetaben(18FBB) PET/CT Imaging to Distinguish Non-cognitively Impaired Subjects and Mild to Moderate Alzheimer Disease Subjects in Chinese Population
Columbia University 2017
Open access · US-GOV
White Matter Hyperintensities in Aging and Dementia
Ege University 2026
Open access · US-GOV